Key result
Levosimendan achieves 100% ROSC versus placebo during resuscitation in a swine cardiac arrest model.
Why the study?
Ischaemic cardiac arrest has poor survival, and the impact of levosimendan on central cardiovascular variables and gas exchange during resuscitation was unknown.
Does levosimendan improve haemodynamic status, gas exchange, and return of spontaneous circulation in a swine model of ischaemic cardiac arrest?
Does levosimendan improve haemodynamic status, gas exchange, and return of spontaneous circulation in a swine model of ischaemic cardiac arrest?
Answers are grounded in this paper and cite their sources.
In a swine model of ischaemic cardiac arrest, levosimendan improved gas exchange, reduced right ventricular afterload, and increased the likelihood of return of spontaneous circulation compared to placebo.
BACKGROUND: Ischaemic cardiac arrest has poor survival. In an earlier animal study, we have shown that levosimendan increases the return of spontaneous circulation and survival compared with placebo. However, the impact of levosimendan on central cardiovascular variables and gas exchange during resuscitation in ischaemic cardiac arrest is unknown. OBJECTIVE: To evaluate levosimendan's dose-response effect on central cardiovascular variables and gas exchange in an established swine cardiac arrest model. DESIGN: A large animal study. SETTING: Animal study with Swedish landrace pigs at Karolinska Institutet, Sweden. INTERVENTION: Ten swine underwent induced acute myocardial infarction and ventricular fibrillation. Levosimendan (62.5 μg kg -1 ) was administered during resuscitation, and immediate outcomes were compared with low dose levosimendan (12 μg kg -1 , n = 12) or placebo ( n = 12) from earlier experiments using the same model. MAIN OUTCOME MEASURES: Haemodynamic and gas exchange variables during resuscitation. Time to and proportion of return to spontaneous circulation. RESULTS: High-dose levosimendan improved gas exchange, with better arterial O 2 and CO 2 levels ( P < 0.01), reduced systolic pulmonary arterial pressure, central venous pressure and vasopressor support with adrenaline after return to spontaneous circulation compared with low dose and placebo ( P = 0.01). All animals in both levosimendan groups achieved return to spontaneous circulation compared with 67% in the placebo group ( P = 0.02). Median [IQR] time to return of spontaneous circulation was 15 min [12 to 18] for high dose 17 min [15 to 26] for low dose compared with 23 min [15 to 60] for placebo ( P = 0.08). CONCLUSIONS: Levosimendan enhances key resuscitation outcomes in the immediate period of ischaemic cardiac arrest, promoting its potential as an effective pharmacological intervention. With an apparent dose-dependent reduction in right ventricular afterload and subsequent improvement in gas exchange, we cautiously propose that levosimendan-induced pulmonary vasodilation alleviates right heart strain and improves interventricular dependency, thereby enhancing the likelihood of return of spontaneous circulation.
No takes yet. Share an insight, caveat, or question.
Rysz et al. (2025) studied Ischaemic cardiac arrest (n=34). Levosimendan vs. Placebo was evaluated on Proportion of return to spontaneous circulation (p=0.02). Levosimendan administration during resuscitation in a swine model of ischaemic cardiac arrest achieved 100% return of spontaneous circulation compared with 67% for placebo (P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: